Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway

Fungal infections are becoming more prevalent and problematic due to the continual rise of immune deficient patients as well as the progressive development of drug resistance towards currently available antifungal drugs. There has been a significant increase in the development of antifungal compound...

Descripción completa

Detalles Bibliográficos
Autores principales: McEvoy, Kyle, Normile, Tyler G., Del Poeta, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559796/
https://www.ncbi.nlm.nih.gov/pubmed/32825250
http://dx.doi.org/10.3390/jof6030142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559796/
https://www.ncbi.nlm.nih.gov/pubmed/32825250
http://dx.doi.org/10.3390/jof6030142

Ejemplares similares